US8741378B1
(en)
|
2001-06-27 |
2014-06-03 |
Advanced Cardiovascular Systems, Inc. |
Methods of coating an implantable device
|
GB0121980D0
(en)
|
2001-09-11 |
2001-10-31 |
Cathnet Science Holding As |
Expandable stent
|
US7137993B2
(en)
|
2001-12-03 |
2006-11-21 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US7309350B2
(en)
|
2001-12-03 |
2007-12-18 |
Xtent, Inc. |
Apparatus and methods for deployment of vascular prostheses
|
US7351255B2
(en)
|
2001-12-03 |
2008-04-01 |
Xtent, Inc. |
Stent delivery apparatus and method
|
US7892273B2
(en)
|
2001-12-03 |
2011-02-22 |
Xtent, Inc. |
Custom length stent apparatus
|
US8080048B2
(en)
|
2001-12-03 |
2011-12-20 |
Xtent, Inc. |
Stent delivery for bifurcated vessels
|
US7294146B2
(en)
|
2001-12-03 |
2007-11-13 |
Xtent, Inc. |
Apparatus and methods for delivery of variable length stents
|
US20040186551A1
(en)
|
2003-01-17 |
2004-09-23 |
Xtent, Inc. |
Multiple independent nested stent structures and methods for their preparation and deployment
|
US7182779B2
(en)
|
2001-12-03 |
2007-02-27 |
Xtent, Inc. |
Apparatus and methods for positioning prostheses for deployment from a catheter
|
US7147656B2
(en)
|
2001-12-03 |
2006-12-12 |
Xtent, Inc. |
Apparatus and methods for delivery of braided prostheses
|
US20030135266A1
(en)
|
2001-12-03 |
2003-07-17 |
Xtent, Inc. |
Apparatus and methods for delivery of multiple distributed stents
|
US7084153B2
(en)
*
|
2002-04-12 |
2006-08-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments comprising steroids and a novel anticholinergic
|
US7241308B2
(en)
*
|
2003-06-09 |
2007-07-10 |
Xtent, Inc. |
Stent deployment systems and methods
|
US7553324B2
(en)
*
|
2003-10-14 |
2009-06-30 |
Xtent, Inc. |
Fixed stent delivery devices and methods
|
US7220755B2
(en)
*
|
2003-11-12 |
2007-05-22 |
Biosensors International Group, Ltd. |
42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
|
US7326236B2
(en)
|
2003-12-23 |
2008-02-05 |
Xtent, Inc. |
Devices and methods for controlling and indicating the length of an interventional element
|
ATE418559T1
(de)
*
|
2004-03-01 |
2009-01-15 |
Terumo Corp |
Verfahren zur herstellung von o-alkylierten rapamycinderivaten
|
US7323006B2
(en)
|
2004-03-30 |
2008-01-29 |
Xtent, Inc. |
Rapid exchange interventional devices and methods
|
US8317859B2
(en)
|
2004-06-28 |
2012-11-27 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US20050288766A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Xtent, Inc. |
Devices and methods for controlling expandable prostheses during deployment
|
US20060034884A1
(en)
*
|
2004-08-10 |
2006-02-16 |
Stenzel Eric B |
Coated medical device having an increased coating surface area
|
US7901451B2
(en)
|
2004-09-24 |
2011-03-08 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method for treating restenosis
|
US8221824B2
(en)
*
|
2005-02-03 |
2012-07-17 |
Boston Scientific Scimed, Inc. |
Deforming surface of drug eluting coating to alter drug release profile of a medical device
|
US7402168B2
(en)
*
|
2005-04-11 |
2008-07-22 |
Xtent, Inc. |
Custom-length stent delivery system with independently operable expansion elements
|
AU2006270221B2
(en)
|
2005-07-15 |
2012-01-19 |
Micell Technologies, Inc. |
Polymer coatings containing drug powder of controlled morphology
|
WO2007011708A2
(en)
|
2005-07-15 |
2007-01-25 |
Micell Technologies, Inc. |
Stent with polymer coating containing amorphous rapamycin
|
US7622477B2
(en)
*
|
2006-02-28 |
2009-11-24 |
Cordis Corporation |
Isomers and 42-epimers of rapamycin alkyl ether analogs, methods of making and using the same
|
WO2007109621A2
(en)
|
2006-03-20 |
2007-09-27 |
Xtent, Inc. |
Apparatus and methods for deployment of linked prosthetic segments
|
EP2019657B1
(de)
|
2006-04-26 |
2015-05-27 |
Micell Technologies, Inc. |
Beschichtungen mit mehreren wirkstoffen
|
US20070281117A1
(en)
|
2006-06-02 |
2007-12-06 |
Xtent, Inc. |
Use of plasma in formation of biodegradable stent coating
|
US20080269865A1
(en)
*
|
2006-08-07 |
2008-10-30 |
Xtent, Inc. |
Custom Length Stent Apparatus
|
WO2008022761A2
(en)
*
|
2006-08-22 |
2008-02-28 |
Novartis Ag |
Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders
|
CN101557814B
(zh)
|
2006-09-13 |
2015-05-20 |
万能医药公司 |
大环内酯化合物及它们的使用方法
|
US10695327B2
(en)
|
2006-09-13 |
2020-06-30 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US8088789B2
(en)
|
2006-09-13 |
2012-01-03 |
Elixir Medical Corporation |
Macrocyclic lactone compounds and methods for their use
|
US8067055B2
(en)
*
|
2006-10-20 |
2011-11-29 |
Biosensors International Group, Ltd. |
Drug-delivery endovascular stent and method of use
|
US20080097591A1
(en)
*
|
2006-10-20 |
2008-04-24 |
Biosensors International Group |
Drug-delivery endovascular stent and method of use
|
US20080103584A1
(en)
*
|
2006-10-25 |
2008-05-01 |
Biosensors International Group |
Temporal Intraluminal Stent, Methods of Making and Using
|
JP5456321B2
(ja)
*
|
2006-11-27 |
2014-03-26 |
テルモ株式会社 |
O−アルキル化ラパマイシン誘導体の製造方法およびo−アルキル化ラパマイシン誘導体
|
US11426494B2
(en)
|
2007-01-08 |
2022-08-30 |
MT Acquisition Holdings LLC |
Stents having biodegradable layers
|
EP2111184B1
(de)
|
2007-01-08 |
2018-07-25 |
Micell Technologies, Inc. |
Stents mit biologisch abbaubaren schichten
|
US20080199510A1
(en)
*
|
2007-02-20 |
2008-08-21 |
Xtent, Inc. |
Thermo-mechanically controlled implants and methods of use
|
US9888924B2
(en)
|
2007-03-06 |
2018-02-13 |
Covidien Lp |
Wound closure material
|
US8486132B2
(en)
|
2007-03-22 |
2013-07-16 |
J.W. Medical Systems Ltd. |
Devices and methods for controlling expandable prostheses during deployment
|
US8661630B2
(en)
|
2008-05-21 |
2014-03-04 |
Abbott Cardiovascular Systems Inc. |
Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
|
EP3459572A1
(de)
*
|
2007-11-14 |
2019-03-27 |
Biosensors International Group, Ltd. |
Automatische beschichtungsverfahren
|
US9101503B2
(en)
|
2008-03-06 |
2015-08-11 |
J.W. Medical Systems Ltd. |
Apparatus having variable strut length and methods of use
|
WO2009131631A1
(en)
*
|
2008-04-14 |
2009-10-29 |
Poniard Pharmaceuticals, Inc. |
Rapamycin analogs as anti-cancer agents
|
MX350637B
(es)
|
2008-04-17 |
2017-09-11 |
Micell Technologies Inc |
Stents que tienen capas bioabsorbibles.
|
US9510856B2
(en)
|
2008-07-17 |
2016-12-06 |
Micell Technologies, Inc. |
Drug delivery medical device
|
US20100055145A1
(en)
*
|
2008-08-29 |
2010-03-04 |
Biosensors International Group |
Stent coatings for reducing late stent thrombosis
|
US11298252B2
(en)
|
2008-09-25 |
2022-04-12 |
Advanced Bifurcation Systems Inc. |
Stent alignment during treatment of a bifurcation
|
CN102215780B
(zh)
|
2008-09-25 |
2015-10-14 |
高级分支系统股份有限公司 |
部分压接支架
|
US8821562B2
(en)
|
2008-09-25 |
2014-09-02 |
Advanced Bifurcation Systems, Inc. |
Partially crimped stent
|
US8769796B2
(en)
|
2008-09-25 |
2014-07-08 |
Advanced Bifurcation Systems, Inc. |
Selective stent crimping
|
DK2365802T3
(da)
|
2008-11-11 |
2017-11-13 |
Univ Texas |
Mikrokapsler af rapamycin og anvendelse til behandling af cancer
|
CN102481195B
(zh)
|
2009-04-01 |
2015-03-25 |
米歇尔技术公司 |
涂覆支架
|
US8460745B2
(en)
*
|
2009-09-20 |
2013-06-11 |
Medtronic Vascular, Inc. |
Apparatus and methods for loading a drug eluting medical device
|
US9283211B1
(en)
|
2009-11-11 |
2016-03-15 |
Rapamycin Holdings, Llc |
Oral rapamycin preparation and use for stomatitis
|
WO2011097103A1
(en)
|
2010-02-02 |
2011-08-11 |
Micell Technologies, Inc. |
Stent and stent delivery system with improved deliverability
|
WO2011119883A1
(en)
|
2010-03-24 |
2011-09-29 |
Advanced Bifurcation Systems, Inc. |
Stent alignment during treatment of a bifurcation
|
CN103037816B
(zh)
|
2010-03-24 |
2018-12-28 |
高级分支系统股份有限公司 |
用于处理分叉部的系统和方法
|
AU2011232360B2
(en)
|
2010-03-24 |
2015-10-08 |
Advanced Bifurcation Systems Inc. |
Methods and systems for treating a bifurcation with provisional side branch stenting
|
US8685433B2
(en)
|
2010-03-31 |
2014-04-01 |
Abbott Cardiovascular Systems Inc. |
Absorbable coating for implantable device
|
WO2011133655A1
(en)
|
2010-04-22 |
2011-10-27 |
Micell Technologies, Inc. |
Stents and other devices having extracellular matrix coating
|
US20130172853A1
(en)
|
2010-07-16 |
2013-07-04 |
Micell Technologies, Inc. |
Drug delivery medical device
|
CN103140494A
(zh)
*
|
2010-08-04 |
2013-06-05 |
美利奴生命科学有限公司 |
制备具有抗增殖特性的新的42-o-(杂烷氧基烷基)雷帕霉素化合物的方法
|
US8632846B2
(en)
*
|
2010-09-17 |
2014-01-21 |
Medtronic Vascular, Inc. |
Apparatus and methods for loading a drug eluting medical device
|
US9120901B2
(en)
|
2010-12-16 |
2015-09-01 |
Sumitomo Seika Chemicals Co., Ltd. |
Method for producing pseudopolyrotaxane
|
CA2821879C
(en)
*
|
2010-12-16 |
2018-07-10 |
Sumitomo Seika Chemicals Co., Ltd. |
Method for producing refined polyrotaxane
|
CA2821887C
(en)
|
2010-12-16 |
2018-07-10 |
Sumitomo Seika Chemicals Co., Ltd. |
Method for producing pseudopolyrotaxane
|
ES2559226T3
(es)
|
2010-12-16 |
2016-02-11 |
Sumitomo Seika Chemicals Co., Ltd. |
Método para producir una dispersión acuosa de pseudopolirrotaxano
|
EP2672932B1
(de)
|
2011-02-08 |
2018-09-19 |
Advanced Bifurcation Systems, Inc. |
System zur behandlung einer gabelung mit einem vollständig gecrimpten stent
|
WO2012109382A2
(en)
|
2011-02-08 |
2012-08-16 |
Advanced Bifurcation Systems, Inc. |
Multi-stent and multi-balloon apparatus for treating bifurcations and methods of use
|
EP2687546B1
(de)
*
|
2011-03-14 |
2015-09-23 |
Sumitomo Seika Chemicals CO. LTD. |
Herstellungsverfahren für pulverförmiges hydrophiles modifiziertes polyrotaxan
|
WO2012124219A1
(ja)
*
|
2011-03-14 |
2012-09-20 |
住友精化株式会社 |
ポリロタキサン組成物
|
EP2687544B1
(de)
*
|
2011-03-14 |
2015-10-14 |
Sumitomo Seika Chemicals CO. LTD. |
Verfahren zur herstellung von hydrophilem modifiziertem polyrotaxan
|
US10188772B2
(en)
|
2011-10-18 |
2019-01-29 |
Micell Technologies, Inc. |
Drug delivery medical device
|
EP2589383A1
(de)
|
2011-11-06 |
2013-05-08 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin |
FKBP-subtypspezifisches Rapamycin-Analogon zur Verwendung bei der Behandlung von Erkrankungen
|
CN104519907A
(zh)
|
2012-03-23 |
2015-04-15 |
昆士兰大学 |
免疫调节剂及其用途
|
KR102011170B1
(ko)
*
|
2012-03-30 |
2019-08-14 |
우베 고산 가부시키가이샤 |
히드록시알킬화 폴리로탁산의 제조 방법
|
US9364273B2
(en)
|
2012-08-15 |
2016-06-14 |
DePuy Synthes Products, Inc. |
Drug eluting surgical screw
|
CN103845290A
(zh)
|
2012-12-03 |
2014-06-11 |
曼丽国际有限公司 |
Umirolimus及其衍生物用于治疗癌症的用途
|
CN105102463B
(zh)
*
|
2013-01-22 |
2017-05-31 |
生物传感器国际集团有限公司 |
雷帕霉素衍生物的低温合成
|
CN110269959A
(zh)
*
|
2013-03-12 |
2019-09-24 |
脉胜医疗技术公司 |
可生物吸收的生物医学植入物
|
EP2968281B1
(de)
|
2013-03-13 |
2020-08-05 |
The Board of Regents of The University of Texas System |
Mtor-hemmer zur vorbeugung von darmpolypenwachstum
|
JP2016519086A
(ja)
|
2013-03-15 |
2016-06-30 |
バイオセンサーズ インターナショナル グループ、リミテッド |
ラパマイシン誘導体の精製
|
US10272606B2
(en)
|
2013-05-15 |
2019-04-30 |
Micell Technologies, Inc. |
Bioabsorbable biomedical implants
|
US20150073998A1
(en)
|
2013-09-09 |
2015-03-12 |
Apple Inc. |
Use of a Biometric Image in Online Commerce
|
AU2014348657A1
(en)
|
2013-11-13 |
2016-05-19 |
Novartis Ag |
mTOR inhibitors for enhancing the immune response
|
CA3225453A1
(en)
|
2013-12-19 |
2015-06-25 |
Novartis Ag |
Human mesothelin chimeric antigen receptors and uses thereof
|
JP6793902B2
(ja)
|
2013-12-20 |
2020-12-02 |
ノバルティス アーゲー |
調節可能キメラ抗原受容体
|
CA3206208A1
(en)
|
2013-12-31 |
2015-07-09 |
Rapamycin Holdings, Llc |
Oral rapamycin nanoparticle preparations and use
|
US9700544B2
(en)
|
2013-12-31 |
2017-07-11 |
Neal K Vail |
Oral rapamycin nanoparticle preparations
|
ES2857226T3
(es)
|
2014-03-15 |
2021-09-28 |
Novartis Ag |
Receptor de antígeno quimérico regulable
|
EP3593812A3
(de)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Behandlung von krebs mithilfe eines chimären antigenrezeptors
|
IL293603B2
(en)
|
2014-04-07 |
2024-03-01 |
Novartis Ag |
Cancer treatment using chimeric antigen receptor (CAR) against CD19
|
WO2016006413A1
(ja)
*
|
2014-07-08 |
2016-01-14 |
国立大学法人大阪大学 |
自己修復性を有する高分子材料及びその製造方法
|
JP2017528433A
(ja)
|
2014-07-21 |
2017-09-28 |
ノバルティス アーゲー |
低い免疫増強用量のmTOR阻害剤とCARの組み合わせ
|
US11542488B2
(en)
|
2014-07-21 |
2023-01-03 |
Novartis Ag |
Sortase synthesized chimeric antigen receptors
|
CN112481283A
(zh)
|
2014-07-21 |
2021-03-12 |
诺华股份有限公司 |
使用cd33嵌合抗原受体治疗癌症
|
US20170209492A1
(en)
|
2014-07-31 |
2017-07-27 |
Novartis Ag |
Subset-optimized chimeric antigen receptor-containing t-cells
|
WO2016025880A1
(en)
|
2014-08-14 |
2016-02-18 |
Novartis Ag |
Treatment of cancer using gfr alpha-4 chimeric antigen receptor
|
MY189028A
(en)
|
2014-08-19 |
2022-01-20 |
Novartis Ag |
Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
|
CN113620978A
(zh)
|
2014-09-11 |
2021-11-09 |
加利福尼亚大学董事会 |
mTORC1抑制剂
|
DK3194443T3
(da)
|
2014-09-17 |
2021-09-27 |
Novartis Ag |
Målretning af cytotoksiske celler med kimære receptorer i forbindelse med adoptiv immunterapi
|
SG11201702895SA
(en)
|
2014-10-08 |
2017-05-30 |
Novartis Ag |
Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof
|
WO2016090034A2
(en)
|
2014-12-03 |
2016-06-09 |
Novartis Ag |
Methods for b cell preconditioning in car therapy
|
WO2016126608A1
(en)
|
2015-02-02 |
2016-08-11 |
Novartis Ag |
Car-expressing cells against multiple tumor antigens and uses thereof
|
EP3280795B1
(de)
|
2015-04-07 |
2021-03-24 |
Novartis AG |
Kombination von chimärer antigen rezeptor therapie und amino pyrimidin derivaten
|
JP7114457B2
(ja)
|
2015-04-17 |
2022-08-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
キメラ抗原受容体発現細胞の有効性および増殖を改善するための方法
|
US20180298068A1
(en)
|
2015-04-23 |
2018-10-18 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor and protein kinase a blocker
|
WO2016185443A1
(en)
|
2015-05-20 |
2016-11-24 |
Novartis Ag |
Pharmaceutical combination of everolimus with dactolisib
|
AR105433A1
(es)
|
2015-07-21 |
2017-10-04 |
Novartis Ag |
Métodos para mejorar la eficacia y expansión de las células inmunes
|
EP3373927A1
(de)
|
2015-11-11 |
2018-09-19 |
Novartis AG |
Verwendungen von myostatin-antagonisten, kombinationen damit und verwendungen davon
|
EP3423482A1
(de)
|
2016-03-04 |
2019-01-09 |
Novartis AG |
Zellen mit expression von mehreren chimären antigenrezeptor (car)-molekülen und verwendungen dafür
|
AR110676A1
(es)
|
2016-10-07 |
2019-04-24 |
Novartis Ag |
Tratamiento del cáncer utilizando receptores de antígenos quiméricos
|
BR112019010470A2
(pt)
|
2016-11-23 |
2019-09-10 |
Novartis Ag |
métodos de realce de resposta imune com everolimo, dactolisib ou ambos
|
WO2018201056A1
(en)
|
2017-04-28 |
2018-11-01 |
Novartis Ag |
Cells expressing a bcma-targeting chimeric antigen receptor, and combination therapy with a gamma secretase inhibitor
|
EP3848065B1
(de)
|
2017-05-15 |
2023-07-26 |
C. R. Bard, Inc. |
Medizinische vorrichtung mit wirkstofffreisetzender beschichtung und zwischenschicht
|
US10596165B2
(en)
|
2018-02-12 |
2020-03-24 |
resTORbio, Inc. |
Combination therapies
|
US20210047405A1
(en)
|
2018-04-27 |
2021-02-18 |
Novartis Ag |
Car t cell therapies with enhanced efficacy
|
US20190336609A1
(en)
|
2018-05-01 |
2019-11-07 |
Revolution Medicines, Inc. |
C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors
|
WO2019213282A1
(en)
|
2018-05-01 |
2019-11-07 |
Novartis Ag |
Biomarkers for evaluating car-t cells to predict clinical outcome
|
AU2019262979B2
(en)
|
2018-05-01 |
2023-07-06 |
Revolution Medicines, Inc. |
C26-linked rapamycin analogs as mTOR inhibitors
|
JP7382353B2
(ja)
|
2018-06-15 |
2023-11-16 |
ヤンセン ファーマシューティカ エヌ.ベー. |
ラパマイシン類似体およびその使用
|
JP7262581B2
(ja)
|
2018-11-14 |
2023-04-21 |
ルトニックス,インコーポレーテッド |
改質されたデバイス表面に薬物溶出コーティングを有する医療用デバイス
|
CN113939324A
(zh)
|
2019-04-08 |
2022-01-14 |
巴德外周血管股份有限公司 |
在经改性装置表面上具有药物洗脱涂层的医疗装置
|
US11517457B2
(en)
*
|
2019-07-03 |
2022-12-06 |
Abbott Cardiovascular Systems Inc. |
Intravascular stent
|
CN115209897A
(zh)
|
2019-12-05 |
2022-10-18 |
安纳库利亚治疗公司 |
雷帕霉素类似物及其用途
|